Patents for A61K 49 - Preparations for testing in vivo (35,376)
05/2007
05/17/2007US20070110675 Method for predicting the developmetn of allergic disease
05/17/2007US20070110674 Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems
05/17/2007US20070110673 Allergen peptide fragments and use thereof
05/17/2007US20070110672 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors
05/17/2007US20070110670 Method for evaluating hair damage using an oxidized protein in hair as an indicator
05/17/2007US20070110669 Methods for In Vivo Evaluation of Pulmonary Physiology And/Or Function Using NMR Signals of Polarized 129Xe
05/17/2007US20070110667 Radionuclide labeling of vitamin B12 and coenzymes thereof
05/17/2007US20070110666 Methods for preparation of live body tissues for examination
05/17/2007US20070110665 Tissue marker for multimodality radiographic imaging
05/16/2007EP1785146A2 Mr-signal emitting coatings
05/16/2007EP1784647A1 Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents
05/16/2007EP1784228A1 Gas-filled microvesicles composition for contrast imaging
05/16/2007EP1784227A2 Mr imaging method for the discrimination between healthy and tumour tissue
05/16/2007EP1784226A2 Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis
05/16/2007EP1085896B1 Conformationally constrained backbone cyclized somatostatin analogs
05/16/2007CN2899735Y Animal or object contamination device
05/16/2007CN1965082A 人源化抗体 Humanized antibodies
05/16/2007CN1964986A Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
05/15/2007US7217788 Controlling immunology; antiinflammatory agents
05/15/2007US7217736 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/15/2007US7217694 Inhibitors of IAPP fibril formation and uses thereof
05/15/2007US7217457 Mixture of hydrophobic polymer core and nanoparticles; immobilization
05/15/2007US7217411 CeSERT genes, proteins, and modulatory compounds
05/15/2007US7217410 Forming image of sample and coated microparticle mixture by exposing to electromagnetic radiation of infrared or ultraviolet frequency; optical coherence tomography, holography, endoscopy; light, confocal, polarization, interference, and/ormulti-photon microscopy
05/15/2007CA2255540C Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/15/2007CA2149419C Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
05/15/2007CA2130452C Altered antibodies, products and processes relating thereto
05/10/2007WO2007053637A2 A tumor susceptible rat with a mutation in apc gene
05/10/2007WO2007051739A2 X-ray system for the creation of diagnostic x-ray images using contrast media
05/10/2007WO2007009637A3 Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy
05/10/2007WO2006102395A3 Delivery systems and methods for diagnosing and treating cardiovascular diseases
05/10/2007WO2006101503A3 Method for screening agents against human prostate disease
05/10/2007WO2006052691A3 Pet and magnetic resonance for screening alzheimer's disease therapeutics
05/10/2007WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri )
05/10/2007US20070107072 Transgenic amphibian models for lymphatic vessel development
05/10/2007US20070105188 determining sperm quality, and different storage media's effect thereon; male fertility
05/10/2007US20070105167 Virulence Associated Nucleic Acid Sequences and Uses Thereof
05/10/2007US20070105147 Rapid method for screening compounds for in vivo activity
05/10/2007US20070104658 Preparing spray-dried particles having a tap density of less than about 0.4 g/cm3 and have a hydrophobic amino acid and a therapeutic, prophylactic or diagnostic agent; pulmonary delivery; respiratory disorders
05/10/2007US20070104650 magnetic resonance imaging; labeling cells with first contrast agent (iron oxide) with magnetic susceptibility sufficient to induce magnetic field inhomogeneity in water molecules, implanting cells in body, obtaining signals, administering second contrast agent (gadolinium), obtaining signals
05/10/2007US20070104649 Optically fluorescent nanoparticles
05/10/2007US20070104648 Compositions, methods of preparing amino acids, and nuclear magnetic resonance spectroscopy
05/10/2007US20070104644 Inhibitor imaging agents
05/09/2007EP1782845A1 Bone cement and X-ray contrast agent and methods of manufacturing the same
05/09/2007EP1781284A1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
05/09/2007EP1781170A1 Adduct of fluorescent dye and tumor avid tetrapyrrole
05/09/2007CN1960754A Cancer regulation antibody
05/09/2007CN1960707A Liposomal assembly for therapeutic and/or diagnostic use
05/09/2007CN1958076A Emulsion spray drying method for preparing ultrasound microbubble contrast agent in batch
05/09/2007CN1314704C Oligopeptide suppressor of matrix metalloprotease 2
05/09/2007CN1314659C Method for preparing ioxitalamic acid
05/09/2007CN1314455C Bone powder mixture and X-ray contras-medium and producing method thereof
05/09/2007CN1314454C Duplication method of chmice acute hyperuricemia model
05/08/2007CA2267498C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
05/08/2007CA2230406C Antimicrobial caries-detecting composition
05/03/2007WO2007051068A2 Compositions and methods for the treatment of aberrant stress response disorders
05/03/2007WO2007050581A2 An albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
05/03/2007WO2007050281A2 Method for indicating shelf-life after mixing pre-dosed, pre-packaged two-part dental compositions
05/03/2007WO2007049264A2 Assays using nanoparticles
05/03/2007WO2007048856A1 Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging
05/03/2007WO2006102536A3 Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
05/03/2007WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
05/03/2007US20070099185 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
05/03/2007US20070098643 Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates
05/03/2007US20070098642 Nanoparticle-based imaging agents for X-ray/computed tomography
05/03/2007US20070098641 Nanoparticle-based imaging agents for X-ray/computed tomography
05/03/2007US20070098640 Nanoparticle-based imaging agents for X-ray/computed tomography
05/03/2007US20070098639 Process for the Preparation of Coated Polymer Particles
05/03/2007US20070098638 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
05/03/2007US20070098637 tissue regeneration using tumors as a source of signals; regenerative potential of the cellular components of arteries, veins, and nerves; tissue engineering
05/03/2007US20070098636 Method of identifying responders to treatment with insulin sensitizers
05/03/2007US20070098635 Secreted polypeptide species associatedwith cardiovascular disorders
05/03/2007US20070098631 Diagnostic compounds comprising a scaffold coupled to a signal entity for medical imaging diagnostic
05/03/2007CA2627287A1 Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging
05/03/2007CA2627155A1 An albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
05/02/2007EP1778858A2 High throughput pharmaceutical screening using drosophila
05/02/2007EP1778651A2 Multivalent chelators for modifying and organizing of target molecules
05/02/2007EP1778299A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications
05/02/2007EP1778298A2 Lipoprotein nanoplatforms
05/02/2007EP1778274A2 Modulation of fiaf and the gastrointestinal microbiota
05/02/2007EP1778159A1 Plural activating optical change toothpastes, stimuli and elements
05/02/2007EP1778082A1 Carboranylporphyrins and uses thereof
05/02/2007EP1519756B1 Use of metal complexes containing perfluoroalkyl as contrast agents in magnetic resonance imaging for representing intravascular thrombi
05/02/2007EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
05/02/2007EP1470127B1 N, n'-dimethylated n-confused porphyrins
05/02/2007EP1135531B1 Methods for introducing heterologous cells into fish
05/02/2007EP1033137B1 Diagnostic reagent for complications associated with diabetes or renal failure
05/02/2007CN1956738A Antibodies to MAdCAM
05/02/2007CN1956678A Optical sensor for in vivo detection of analyte
05/02/2007CN1954888A Chinese medicine capsule for stomach ultrasonic image
05/02/2007CN1954887A Preparation method of screening mould of external anti-tumor medicine
05/02/2007CN1313160C Doped cerium alkaline earth hafnium dioxide scintillator and mfg. method thereof
05/01/2007US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
05/01/2007US7211401 Method for the detection of prion diseases
05/01/2007US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand
05/01/2007US7211240 Multivalent constructs for therapeutic and diagnostic applications
04/2007
04/26/2007WO2007047815A2 Diagnosis of transmissible spongiform encephalopathy
04/26/2007WO2007047668A2 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells
04/26/2007WO2007047141A2 Transgenic ro s a26-luc i f eras e mice for bioluminescent imaging
04/26/2007WO2007045903A2 Methods of analysing cell behaviour